Heterozygosity for C1 inhibitor (C1INH) deficiency results in hereditary angioedema. Disruption of the C1INH gene by gene trapping enabled the generation of homozygous- and heterozygous-deficient mice. Mating of heterozygous-deficient mice resulted in the expected 1:2:1 ratio of wild-type, heterozygous, and homozygous-deficient offspring. C1INH-deficient mice showed no obvious phenotypic abnormality. However, following injection with Evans blue dye, both homozygous and heterozygous C1INH-deficient mice revealed increased vascular permeability in comparison with wild-type littermates. This increased vascular permeability was reversed by treatment with intravenous human C1INH, with a Kunitz domain plasma kallikrein inhibitor (DX88), and with a bradykinin type 2 receptor (Bk2R) antagonist (Hoe140). In addition, treatment of the C1INH-deficient mice with an angiotensin-converting enzyme inhibitor (captopril) increased the vascular permeability. Mice with deficiency of both C1INH and Bk2R demonstrated diminished vascular permeability in comparison with C1INH-deficient, Bk2R-sufficient mice. These data support the hypothesis that angioedema is mediated by bradykinin via Bk2R.
Eun D. Han, Ryan C. MacFarlane, Aideen N. Mulligan, Jennifer Scafidi, Alvin E. Davis III
Title and authors | Publication | Year |
---|---|---|
Elevated level of circulating VEGF in Chinese patients with hereditary angioedema and its correlation with disease status
Ji R, Xu Y, Zhi Y |
Orphanet Journal of Rare Diseases | 2025 |
Potential Pathways and Pathophysiological Implications of Viral Infection-Driven Activation of Kallikrein–Kinin System (KKS)
Coelho SV, Augusto FM, de Arruda LB |
Viruses | 2024 |
Discovery of α-Amidobenzylboronates as Highly Potent Covalent Inhibitors of Plasma Kallikrein
Allison M, Davie RL, Mogg AJ, Hampton SL, Emsley J, Stocks MJ |
ACS Medicinal Chemistry Letters | 2024 |
Evaluation of Urtica dioica Phytochemicals against Therapeutic Targets of Allergic Rhinitis Using Computational Studies.
Culhuac EB, Bello M |
Molecules (Basel, Switzerland) | 2024 |
Hereditary angioedema classification: Expanding knowledge by genotyping and endotyping.
Giavina-Bianchi P, Vivolo Aun M, Giavina-Bianchi M, Ribeiro AJ, Camara Agondi R, Motta AA, Kalil J |
The World Allergy Organization journal | 2024 |
Androgen transition and management of hereditary angioedema long-term prophylaxis in real life: a single-center case series
Hoarau C, Maleki A, Bouillet L, Boccon-Gibod I |
Orphanet Journal of Rare Diseases | 2024 |
Prolonging the circulatory half-life of C1 esterase inhibitor via albumin fusion
Sivananthan S, Bhakta V, Chaechi Tehrani N, Sheffield WP |
PLOS ONE | 2024 |
Hereditary Angioedema and Venous Thromboembolism: Where there’s smoke, there’s fire
Grover SP |
Seminars in thrombosis and hemostasis | 2024 |
Pharmacokinetics, Pharmacodynamics, and Safety of Subcutaneous and Intravenous Garadacimab Following Single‐Dose Administration in Healthy Japanese and White Adults
Glassman F, Lawo J, Bica MA, Roberts A, Pawaskar D, Akama H, Jain M, Goodson S |
Journal of Clinical Pharmacology | 2024 |
ZNF185 prevents stress fiber formation through the inhibition of RhoA in endothelial cells
Suzuki S, Ando F, Kitagawa S, Hara Y, Fujiki T, Mandai S, Susa K, Mori T, Sohara E, Rai T, Uchida S |
Communications biology | 2023 |
Complementing Testicular Immune Regulation: The Relationship between Sertoli Cells, Complement, and the Immune Response
Washburn RL, Dufour JM |
International journal of molecular sciences | 2023 |
C1 inhibitor deficiency enhances contact pathway–mediated activation of coagulation and venous thrombosis
Grover SP, Kawano T, Wan J, Tanratana P, Polai Z, Shim YJ, Snir O, Brækkan S, Dhrolia S, Kasthuri RR, Bendapudi PK, McCrae KR, Wolberg AS, Hansen JB, Farkas H, Mackman N |
Blood | 2023 |
6-(Arylaminomethyl) Isoquinolines as Enzyme Inhibitors and Their Preparation: A Patent Highlight of Factor XIIa Inhibitors
Al-Horani RA |
Cardiovascular & hematological agents in medicinal chemistry | 2023 |
Hypersensitivity reactions amongst Hungarian Patients with Hereditary Angioedema due to C1-Inhibitor Deficiency
Horváth HR, Szilágyi D, Andrási N, Balla Z, Visy B, Farkas H |
The World Allergy Organization journal | 2023 |
Pathophysiology of bradykinin and histamine mediated angioedema
Lima H, Zheng J, Wong D, Waserman S, Sussman GL |
2023 | |
Anticoagulant SERPINs: Endogenous Regulators of Hemostasis and Thrombosis
S Grover, N Mackman |
Frontiers in Cardiovascular Medicine | 2022 |
The innate immune response, microenvironment proteinases, and the COVID-19 pandemic: pathophysiologic mechanisms and emerging therapeutic targets
M Hollenberg, M Epstein |
Kidney International Supplements | 2022 |
Treatment of hereditary angioedema—single or multiple pathways to the rescue
Valerieva A, Longhurst HJ |
2022 | |
Alloferon-1 ameliorates acute inflammatory responses in λ-carrageenan-induced paw edema in mice
Zhang X, Retyunskiy V, Qiao S, Zhao Y, Tzeng CM |
Scientific Reports | 2022 |
A novel murine in vivo model for acute hereditary angioedema attacks
S Bupp, M Whittaker, M Lehtimaki, JM Park, J Dement-Brown, ZH Zhou, S Kozlowski |
Scientific Reports | 2021 |
Kinins and Their Receptors as Potential Therapeutic Targets in Retinal Pathologies
R Othman, G Cagnone, JS Joyal, E Vaucher, R Couture |
Cells | 2021 |
Molecular Dambusters: What Is Behind Hyperpermeability in Bradykinin-Mediated Angioedema?
ML Debreczeni, Z Németh, E Kajdácsi, H Farkas, L Cervenak |
Clinical Reviews in Allergy & Immunology | 2021 |
gC1qR Antibody Can Modulate Endothelial Cell Permeability in Angioedema
M Fandaros, K Joseph, AP Kaplan, DA Rubenstein, B Ghebrehiwet, W Yin |
Inflammation | 2021 |
Rediscovery of a forgotten disease: Hereditary Angioedema
O Gulbahar, A Germenis |
BALK MED J | 2021 |
Penicillin causes non-allergic anaphylaxis by activating the contact system
Y Gao, Y Han, X Zhang, Q Fei, R Qi, R Hou, R Cai, C Peng, Y Qi |
Scientific Reports | 2020 |
Role of Endothelial G Protein-Coupled Receptor Kinase 2 in Angioedema
J Gambardella, D Sorriento, M Bova, M Rusciano, S Loffredo, X Wang, A Petraroli, L Carucci, I Mormile, M Oliveti, MB Morelli, A Fiordelisi, G Spadaro, P Campiglia, M Sala, B Trimarco, G Iaccarino, G Santulli, M Ciccarelli |
Hypertension | 2020 |
In Vitro Modeling of Bradykinin-Mediated Angioedema States
F Marceau, H Bachelard, X Charest-Morin, J Hébert, GE Rivard |
Pharmaceuticals (Basel, Switzerland) | 2020 |
Knockdown of circulating C1 inhibitor induces neurovascular impairment, glial cell activation, neuroinflammation, and behavioral deficits
D Farfara, E Feierman, A Richards, AS Revenko, RA MacLeod, EH Norris, S Strickland |
Glia | 2019 |
Gene therapy for C1 esterase inhibitor deficiency in a Murine Model of Hereditary angioedema
T Qiu, MJ Chiuchiolo, AS Whaley, AR Russo, D Sondhi, SM Kaminsky, RG Crystal, OE Pagovich |
Allergy | 2019 |
Use of a Mouse Model and Human Umbilical Vein Endothelial Cells to Investigate the Effect of Arsenic Exposure on Vascular Endothelial Function and the Associated Role of Calpains
Z Cai, Y Zhang, Y Zhang, X Miao, S Li, H Yang, Q Ling, PR Hoffmann, Z Huang |
Environmental Health Perspectives | 2019 |
The Influence of ACE Inhibition on C1-Inhibitor: A Biomarker for ACE Inhibitor-Induced Angioedema?
J Hahn, M Nordmann-Kleiner, C Bönner, G Kojda, TK Hoffmann, J Greve |
Biomedicine Hub | 2019 |
The Hereditary Angioedema Syndromes
Alvin H. Schmaier |
Journal of Clinical Investigation | 2018 |
Plasma Prekallikrein: Its Role in Hereditary Angioedema and Health and Disease
AH Schmaier |
Frontiers in Medicine | 2018 |
The role of bradykinin receptor type 2 in spontaneous extravasation in mice skin: implications for non-allergic angio-oedema: Bradykinin B 2 receptor in spontaneous permeability
M Bisha, VT Dao, E Gholamreza-Fahimi, M Vogt, M van Zandvoort, S Weber, M Bas, F Khosravani, G Kojda, T Suvorava |
British Journal of Pharmacology | 2018 |
Sensing of Vascular Permeability in Inflamed Vessel of Live Animal
SA Park, S Jeong, YH Choe, YM Hyun |
Journal of Automated Methods and Management in Chemistry | 2018 |
Brazilian Guidelines for Hereditary Angioedema Management - 2017 Update Part 1: Definition, Classification and Diagnosis
P Giavina-Bianchi, LK Arruda, MV Aun, RA Campos, HJ Chong-Neto, RN Constantino-Silva, Fernandes, MF Ferraro, MP Ferriani, AT França, G Fusaro, JF Garcia, S Komninakis, LS Maia, E Mansour, AS Moreno, AA Motta, JB Pesquero, N Portilho, NA Rosário, FS Serpa, D Solé, P Takejima, E Toledo, SO Valle, CL Veronez, AS Grumach |
Clinics | 2018 |
Hereditary angioedema: Linking complement regulation to the coagulation system
M Levi, DM Cohn, S Zeerleder |
Research and Practice in Thrombosis and Haemostasis | 2018 |
An investigational RNAi therapeutic targeting Factor XII (ALN-F12) for the treatment of hereditary angioedema
J Liu, J Qin, A Borodovsky, T Racie, A Castoreno, M Schlegel, MA Maier, T Zimmerman, K Fitzgerald, J Butler, A Akinc |
RNA (New York, N.Y.) | 2018 |
Current and future therapies for the treatment of histamine-induced angioedema
C James, JA Bernstein |
Expert Opinion on Pharmacotherapy | 2017 |
Serping1/C1 Inhibitor Affects Cortical Development in a Cell Autonomous and Non-cell Autonomous Manner
A Gorelik, T Sapir, TM Woodruff, O Reiner |
Frontiers in cellular neuroscience | 2017 |
Factor XII-Driven Inflammatory Reactions with Implications for Anaphylaxis
L Bender, H Weidmann, S Rose-John, T Renné, AT Long |
Frontiers in immunology | 2017 |
The Effects of the Contact Activation System on Hemorrhage
F Simão, EP Feener |
Frontiers in Medicine | 2017 |
Hereditary angioedema: Assessing the hypothesis for underlying autonomic dysfunction
MA Wu, F Casella, F Perego, C Suffritti, NA Afifi, E Tobaldini, A Zanichelli, C Cogliati, N Montano, M Cicardi, M Bader |
PloS one | 2017 |
The Search for Biomarkers in Hereditary Angioedema
AP Kaplan, C Maas |
Frontiers in Medicine | 2017 |
Pharmacological Management of Hereditary Angioedema with C1-Inhibitor Deficiency in Pediatric Patients
H Farkas |
Pediatric Drugs | 2017 |
Complement, Kinins, and Hereditary Angioedema: Mechanisms of Plasma Instability when C1 Inhibitor is Absent
AP Kaplan, K Joseph |
Clinical Reviews in Allergy & Immunology | 2016 |
HAE Pathophysiology and Underlying Mechanisms
BL Zuraw, SC Christiansen |
Clinical Reviews in Allergy & Immunology | 2016 |
The Story of Angioedema: from Quincke to Bradykinin
A Reshef, M Kidon, I Leibovich |
Clinical Reviews in Allergy & Immunology | 2016 |
The Kallikrein-Kinin System: A Novel Mediator of IL-17-Driven Anti-Candida Immunity in the Kidney
K Ramani, AV Garg, CV Jawale, HR Conti, N Whibley, EK Jackson, SS Shiva, W Horne, JK Kolls, SL Gaffen, PS Biswas, DJ Krysan |
PLoS pathogens | 2016 |
The initiation and effects of plasma contact activation: an overview
L Lin, M Wu, J Zhao |
International Journal of Hematology | 2016 |
Hereditary Angioedema as a Metabolic Liver Disorder: Novel Therapeutic Options and Prospects for Cure
R Ameratunga, A Bartlett, J McCall, R Steele, ST Woon, CH Katelaris |
Frontiers in immunology | 2016 |
Evidence and evidence gaps of medical treatment of non-tumorous diseases of the head and neck
Murat Bas |
GMS Current Topics in Otorhinolaryngology, Head and Neck Surgery | 2016 |
Haploinsufficiency of Klippel-Trenaunay syndrome gene Aggf1 inhibits developmental and pathological angiogenesis by inactivating PI3K and AKT and disrupts vascular integrity by activating VE-cadherin
T Zhang, Y Yao, J Wang, Y Li, P He, V Pasupuleti, Z Hu, X Jia, Q Song, XL Tian, C Hu, Q Chen, QK Wang |
Human Molecular Genetics | 2016 |
Defective glycosylation of coagulation factor XII causes hereditary angioedema type III
Jenny Björkqvist, Steven de Maat, Urs Lewandrowski, Antonio Di Gennaro, Chris Oschatz, Kai Schönig, Markus Noethen, Christian Drouet, Hal Braley, Marc W Nolte, Albert Sickmann, Con Panousis, Coen Maas, Thomas Renne |
Journal of Clinical Investigation | 2015 |
Amniotic Fluid Embolism Pathophysiology Suggests the New Diagnostic Armamentarium: β-Tryptase and Complement Fractions C3-C4 Are the Indispensable Working Tools
F Busardò, P Frati, S Zaami, V Fineschi |
International journal of molecular sciences | 2015 |
Analgesic and Anti-Inflammatory Properties of Gelsolin in Acetic Acid Induced Writhing, Tail Immersion and Carrageenan Induced Paw Edema in Mice
AK Gupta, D Parasar, A Sagar, V Choudhary, BS Chopra, R Garg, A ., N Khatri, PK Datta |
PloS one | 2015 |
CTRP6 is an endogenous complement regulator that can effectively treat induced arthritis
MA Murayama, S Kakuta, A Inoue, N Umeda, T Yonezawa, T Maruhashi, K Tateishi, H Ishigame, R Yabe, S Ikeda, A Seno, HH Chi, Y Hashiguchi, R Kurata, T Tada, S Kubo, N Sato, Y Liu, M Hattori, S Saijo, M Matsushita, T Fujita, T Sumida, Y Iwakura |
Nature Communications | 2015 |
A Consensus Parameter for the Evaluation and Management of Angioedema in the Emergency Department
JJ Moellman, JA Bernstein, C Lindsell, A Banerji, PJ Busse, CA Camargo, SP Collins, TJ Craig, WR Lumry, R Nowak, JM Pines, AS Raja, M Riedl, MJ Ward, BL Zuraw, D Diercks, B Hiestand, RL Campbell, S Schneider, R Sinert, JN Goldstein |
Academic Emergency Medicine | 2014 |
C-reactive protein levels in hereditary angioedema: C-reactive protein levels in hereditary angioedema
ZL Hofman, A Relan, CE Hack |
Clinical & Experimental Immunology | 2014 |
ARF6 Inhibition Stabilizes the Vasculature and Enhances Survival during Endotoxic Shock
CT Davis, W Zhu, CC Gibson, JA Bowman-Kirigin, L Sorensen, J Ling, H Sun, S Navankasattusas, DY Li |
Journal of immunology (Baltimore, Md. : 1950) | 2014 |
Pathophysiology of Hereditary Angioedema
S Caccia, C Suffritti, M Cicardi |
Pediatric Allergy, Immunology, and Pulmonology | 2014 |
Reduced thrombosis in Klkb1-/- mice is mediated by increased Mas receptor, prostacyclin, Sirt1, and KLF4 and decreased tissue factor
EX Stavrou, C Fang, A Merkulova, O Alhalabi, N Grobe, S Antoniak, N Mackman, AH Schmaier |
Blood | 2014 |
Hereditary Angioedema Attacks: Local Swelling at Multiple Sites
ZL Hofman, A Relan, CE Hack |
Clinical Reviews in Allergy & Immunology | 2014 |
Vasoinhibins regulate the inner and outer blood-retinal barrier and limit retinal oxidative stress
DA Zamarripa, N DÃaz-Lezama, RM GarcÃa, Jà Balderas, N Adán, MG Ledesma-Colunga, E Arnold, C Clapp, Sà Thebault |
Frontiers in cellular neuroscience | 2014 |
Icatibant, an inhibitor of bradykinin receptor 2, for hereditary angioedema attacks: prospective experimental single-cohort study
Campos RA, Valle SO, França AT, Cordeiro E, Serpa FS, Mello YF, Malheiros T, Toledo E, Mansour E, Fusaro G, Grumach AS |
2014 | |
Podoplanin maintains high endothelial venule integrity by interacting with platelet CLEC-2
BH Herzog, J Fu, SJ Wilson, PR Hess, A Sen, JM McDaniel, Y Pan, M Sheng, T Yago, R Silasi-Mansat, S McGee, F May, B Nieswandt, AJ Morris, F Lupu, SR Coughlin, RP McEver, H Chen, ML Kahn, L Xia |
Nature | 2013 |
Hereditary angioedema: epidemiology, management, and role of icatibant
A Ghazi, JA Grant |
Biologics : targets & therapy | 2013 |
Using the Past to Inform the Future: Anti-VEGF Therapy as a Road Map to Develop Novel Therapies for Diabetic Retinopathy
PM Titchenell, DA Antonetti |
Diabetes | 2013 |
Pollen Count and Presentation of Angiotensin-Converting Enzyme Inhibitor–Associated Angioedema
B Straka, H Nian, C Sloan, JB Byrd, A Woodard-Grice, C Yu, E Stone, G Steven, T Hartert, KK Teo, G Pare, CA McCarty, NJ Brown |
The Journal of Allergy and Clinical Immunology: In Practice | 2013 |
Complement C1 Esterase Inhibitor Levels Linked to Infections and Contaminated Heparin-Associated Adverse Events
ZH Zhou, T Chen, K Arora, K Hyams, S Kozlowski |
PloS one | 2012 |
The effect of C1 inhibitor on myocardial ischemia and reperfusion injury
F Lu, SM Fernandes, AE Davis |
Cardiovascular Pathology | 2012 |
In vivo roles of factor XII
T Renne, AH Schmaier, KF Nickel, M Blomback, C Maas |
Blood | 2012 |
The autoreactivity of B cells in hereditary angioedema due to C1 inhibitor deficiency: B cell autoreactivity in HAE
A Kessel, R Peri, R Perricone, MD Guarino, Z Vadasz, R Novak, T Haj, S Kivity, E Toubi |
Clinical & Experimental Immunology | 2012 |
Bradykinin and the Pathogenesis of Hereditary Angioedema
AP Kaplan |
World Allergy Organization Journal | 2011 |
The procoagulant and proinflammatory plasma contact system
T Renné |
Seminars in Immunopathology | 2011 |
Therapeutic Approaches in Hereditary Angioedema
SA Antoniu |
Clinical Reviews in Allergy & Immunology | 2011 |
Brazilian guidelines for the diagnosis and treatment of hereditary angioedema
P Giavina-Bianchi, AT França, AS Grumach, AA Motta, FR Fernandes, RA Campos, SO Valle, NA Rosário, D Sole |
Clinics | 2011 |
The New Era of C1-Esterase Inhibitor Deficiency Therapy
LM Tourangeau, BL Zuraw |
Current Allergy and Asthma Reports | 2011 |
Plasma Kallikrein Mediates Retinal Vascular Dysfunction and Induces Retinal Thickening in Diabetic Rats
A Clermont, TJ Chilcote, T Kita, J Liu, P Riva, S Sinha, EP Feener |
Diabetes | 2011 |
The Pathophysiology of Hereditary Angioedema
BL Zuraw |
World Allergy Organization Journal | 2010 |
Factor XII: what does it contribute to our understanding of the physiology and pathophysiology of hemostasis & thrombosis
E Stavrou, AH Schmaier |
Thrombosis Research | 2010 |
Why do we want to know how factor XII levels are modulated?
AH Schmaier |
Thrombosis Research | 2010 |
Obstetrical Complications and Outcome in Two Families with Hereditary Angioedema due to Mutation in the F12 Gene
O Picone, AC Donnadieu, FG Brivet, C Boyer-Neumann, V Frémeaux-Bacchi, R Frydman |
Obstetrics and Gynecology International | 2010 |
Hookworm (Necator americanus) Larval Enzymes Disrupt Human Vascular Endothelium
N Souadkia, A Brown, L Leach, DI Pritchard |
The American journal of tropical medicine and hygiene | 2010 |
Hereditary Angioedema Therapy: Kallikrein Inhibition and Bradykinin Receptor Antagonism:
M Riedl |
World Allergy Organization Journal | 2010 |
Icatibant:
ED Deeks |
Drugs | 2010 |
Icatibant, a New Bradykinin-Receptor Antagonist, in Hereditary Angioedema
M Cicardi, A Banerji, F Bracho, A Malbrán, B Rosenkranz, M Riedl, K Bork, W Lumry, W Aberer, H Bier, M Bas, J Greve, TK Hoffmann, H Farkas, A Reshef, B Ritchie, W Yang, J Grabbe, S Kivity, W Kreuz, RJ Levy, T Luger, K Obtulowicz, P Schmid-Grendelmeier, C Bull, B Sitkauskiene, WB Smith, E Toubi, S Werner, S Anné, J Björkander, L Bouillet, E Cillari, D Hurewitz, KW Jacobson, CH Katelaris, M Maurer, H Merk, JA Bernstein, C Feighery, B Floccard, G Gleich, J Hébert, M Kaatz, P Keith, CH Kirkpatrick, D Langton, L Martin, C Pichler, D Resnick, D Wombolt, DS Romero, A Zanichelli, F Arcoleo, J Knolle, I Kravec, L Dong, J Zimmermann, K Rosen, WT Fan |
New England Journal of Medicine | 2010 |
Kruppel-Like Factor 2 Regulates Endothelial Barrier Function
Z Lin, V Natesan, H Shi, F Dong, D Kawanami, GH Mahabeleshwar, GB Atkins, L Nayak, Y Cui, JH Finigan, MK Jain |
Arteriosclerosis, thrombosis, and vascular biology | 2010 |
HAE therapies: past present and future
BL Zuraw |
Allergy Asthma & Clinical Immunology | 2010 |
Hereditary Angioedema in Childhood: An Approach to Management
DG Ebo, MM Verweij, KJ Knop, MM Hagendorens, CH Bridts, LS Clerck, WJ Stevens |
Pediatric Drugs | 2010 |
Hereditary Angioedema Therapy: Kallikrein Inhibition and Bradykinin Receptor Antagonism
Riedl M |
The World Allergy Organization journal | 2010 |
The Pathophysiology of Hereditary Angioedema
BL Zuraw |
World Allergy Organization Journal | 2010 |
Coughing Precipitated by Bordetella pertussis Infection
M Hewitt, BJ Canning |
Lung | 2009 |
Novel pathogenic mechanism and therapeutic approaches to angioedema associated with C1 inhibitor deficiency
F Bossi, F Fischetti, D Regoli, P Durigutto, B Frossi, F Gobeil, B Ghebrehiwet, EI Peerschke, M Cicardi, F Tedesco |
Journal of Allergy and Clinical Immunology | 2009 |
Platelet polyphosphates are proinflammatory and procoagulant mediators in vivo
F Müller, NJ Mutch, WA Schenk, SA Smith, L Esterl, HM Spronk, S Schmidbauer, WA Gahl, JH Morrissey, T Renné |
Cell | 2009 |
Assembly, activation, and physiologic influence of the plasma kallikrein/kinin system
AH Schmaier |
International Immunopharmacology | 2008 |
Proteomic analysis of skin invasion by blood fluke larvae
E Hansell, S Braschi, KF Medzihradszky, M Sajid, M Debnath, J Ingram, KC Lim, JH McKerrow |
PLoS neglected tropical diseases | 2008 |
Effect of bradykinin metabolism inhibitors on evoked hypotension in rats: rank efficacy of enzymes associated with bradykinin-mediated angioedema: Bradykinin-mediated angioedema: enzyme efficacy
RM Fryer, J Segreti, PN Banfor, DL Widomski, BJ Backes, CW Lin, SJ Ballaron, BF Cox, JM Trevillyan, GA Reinhart, TW Geldern |
British Journal of Pharmacology | 2008 |
Metallopeptidase activities in hereditary angioedema: Effect of androgen prophylaxis on plasma aminopeptidase P
C Drouet, A Désormeaux, J Robillard, D Ponard, L Bouillet, L Martin, G Kanny, DA Moneret-Vautrin, JL Bosson, JL Quesada, M López-Trascasa, A Adam |
Journal of Allergy and Clinical Immunology | 2008 |
Current and Emerging Management Options for Hereditary Angioedema in the US:
TG Epstein, JA Bernstein |
Drugs | 2008 |
Angioödem
HF Merk |
Der Hautarzt | 2007 |
Bradykinin B2 receptor knockout mice are protected from thrombosis by increased nitric oxide and prostacyclin
Z Shariat-Madar, F Mahdi, M Warnock, JW Homeister, S Srikanth, Y Krijanovski, LJ Murphey, AA Jaffa, AH Schmaier |
Blood | 2006 |
Induction of transient macroapertures in endothelial cells through RhoA inhibition by Staphylococcus aureus factors
L Boyer, A Doye, M Rolando, G Flatau, P Munro, P Gounon, R Clément, C Pulcini, MR Popoff, A Mettouchi, L Landraud, O Dussurget, E Lemichez |
The Journal of Cell Biology | 2006 |
Akt1 regulates pathological angiogenesis, vascular maturation and permeability in vivo
J Chen, PR Somanath, O Razorenova, WS Chen, N Hay, P Bornstein, TV Byzova |
Nature Medicine | 2005 |
C1 inhibitor: molecular and clinical aspects
M Cicardi, L Zingale, A Zanichelli, E Pappalardo, B Cicardi |
Springer Seminars in Immunopathology | 2005 |
C1 inhibitor deficiency: consensus document
MM Gompels, RJ Lock, M Abinun, CA Bethune, G Davies, C Grattan, AC Fay, HJ Longhurst, L Morrison, A Price, M Price, D Watters |
Clinical & Experimental Immunology | 2005 |
Defective thrombus formation in mice lacking coagulation factor XII
T Renné, M Pozgajová, S Grüner, K Schuh, HU Pauer, P Burfeind, D Gailani, B Nieswandt |
Journal of Experimental Medicine | 2005 |
The powerful neuroprotective action of C1-inhibitor on brain ischemia-reperfusion injury does not require C1q
MG de Simoni, E Rossi, C Storini, S Pizzimenti, C Echart, L Bergamaschini |
The American Journal of Pathology | 2004 |
Hereditary angioedema: The rewards of studying a rare disease
MM Frank |
Current Allergy and Asthma Reports | 2004 |
Hereditary and acquired angioedema: Problems and progress: Proceedings of the third C1 esterase inhibitor deficiency workshop and beyond
A Agostoni, E Aygorenpursun, K Binkley, A Blanch, K Bork, L Bouillet, C Bucher, A Castaldo, M Cicardi, A DAVISIII |
Journal of Allergy and Clinical Immunology | 2004 |
The plasma kallikrein/kinin system counterbalances the renin angiotensin system
Alvin Schmaier |
Journal of Clinical Investigation | 2002 |